Discover your unique microbiome profile with advanced testing

Learn More →
Microbiome & Health

ADHD and Gut Health: What the Microbiome Research Shows

Research links ADHD to altered gut bacteria, lower short-chain fatty acids, and higher IBS rates. What the evidence shows on gut health, diet and probiotics.

Neurological Gut-Brain Axis Neurodevelopmental
5-7%
Estimated worldwide prevalence of ADHD in children and adolescents
1.63x
Higher odds of irritable bowel syndrome in people with ADHD (pooled across 11 studies)
5 of 6
Short-chain fatty acids measured significantly lower in children with ADHD in one 2024 case-control study
Medically reviewed: September 9, 2026

ADHD and gut health are connected, but not in the way most headlines suggest. Studies consistently find that people with ADHD carry a different mix of gut bacteria and produce fewer short-chain fatty acids than people without it, and rates of constipation, abdominal pain and irritable bowel syndrome are measurably higher. What the evidence does not show is that gut bacteria cause ADHD. Diet, fiber and specific probiotic strains are being tested as adjuncts to standard treatment — not as replacements for it.

Key Takeaways

  • ADHD is associated with measurable differences in gut microbiome composition, including reduced butyrate-producing bacteria, elevated Blautia, and altered Bifidobacterium abundance[1][2]
  • Children with ADHD had significantly lower concentrations of five of six measured fecal short-chain fatty acids in a 2024 case-control study[3]
  • Gastrointestinal comorbidity is real and quantified: pooled odds of irritable bowel syndrome are 1.63 times higher in ADHD across 3.85 million people[4]
  • Stimulant medication independently raises the risk of abdominal pain and appetite loss, which confounds much of the microbiome literature[5]
  • Fecal microbiota transfer from ADHD patients to mice changes brain gene expression and connectivity, supporting a functional role for the microbiome[6]
  • Causality has not been demonstrated in humans; microbiome-targeted strategies should complement, not replace, established ADHD treatment

Overview: ADHD, the Gut, and Why the Two Keep Appearing Together

Attention-deficit/hyperactivity disorder is a neurodevelopmental condition characterized by persistent inattention, hyperactivity and impulsivity that interfere with functioning and development. It affects an estimated 5-7% of children and around 2.5% of adults worldwide, and is recognized as a lifelong condition in many individuals.[7]

The pathophysiology involves dysregulated dopaminergic and noradrenergic neurotransmission, and conventional treatment typically combines stimulant medication (such as methylphenidate and amphetamines) with behavioral intervention. The reason gut health entered this picture at all is empirical rather than theoretical: clinicians kept observing that children with ADHD reported gastrointestinal symptoms, food sensitivities and symptom changes in response to dietary interventions at rates that were hard to dismiss.[8]

The diet-microbiome-brain axis offers a framework for those observations. Gut bacteria influence dopamine precursor availability, neuroinflammation and neurotransmitter synthesis — all processes relevant to ADHD.[7] For a broader introduction to the underlying biology, see our overview of the gut-brain connection.

How Gut Health Affects ADHD: Five Pathways

Five mechanisms are repeatedly proposed to connect gut microbial composition to the neurotransmitter dysregulation and behavioral features of ADHD. None is proven to drive the disorder; each has supporting observational data.

Pathway How it works What has been observed in ADHD
Dopamine precursor metabolism Gut bacteria carry enzymes in the phenylalanine and tyrosine pathways that sit upstream of dopamine synthesis Increased abundance of bacterial cyclohexadienyl dehydratase[9]; significant differences in serotonin and dopamine metabolic pathways in ADHD children[10]
Short-chain fatty acid production Bacterial fermentation of fiber yields butyrate, propionate and acetate, which reach the brain and modulate inflammation and BDNF expression Acetic, propionic, isobutyric, isovaleric and valeric acids all significantly lower in children with ADHD versus controls[3]
Immune and inflammatory signaling Endotoxin and cytokines entering circulation promote low-grade systemic and neuro-inflammation Elevated soluble adhesion molecules in adults with ADHD; SCFA levels correlated inversely with inflammatory markers[11]
Gut barrier integrity Butyrate producers fuel colonocytes and support tight junctions; their loss may increase intestinal permeability Decreased Faecalibacterium prausnitzii reported across observational studies[12]
Vagal and HPA-axis signaling Direct neural communication and cortisol-mediated stress response link gut state to arousal and emotional regulation Mechanistically plausible and demonstrated in animal models, but not yet directly measured in ADHD cohorts

The strongest experimental support for any causal role comes from animal work. Colonizing germ-free mice with gut microbiota from people with ADHD produced changes in brain gene expression and structural connectivity relative to mice receiving control microbiota.[6] That establishes that an ADHD-associated microbial community can alter brain biology; it does not establish that it does so in humans.

The ADHD Gut Microbiome: What Studies Actually Found

Several independent meta-analyses now converge on a recurring pattern, though individual taxa remain inconsistent between cohorts. The table below summarizes the taxa with the most repeated findings.

Bacterium Direction in ADHD What it does Evidence strength
Bifidobacterium Conflicting — increased in some cohorts, reduced in pooled analyses Ferments fiber and human milk oligosaccharides; some species produce GABA Moderate but genuinely inconsistent[9][1]
Lactobacillus Reduced Lactic acid producer; certain strains modulate GABA receptor expression in animal models Moderate (meta-analytic)[1]
Faecalibacterium prausnitzii Reduced One of the largest butyrate producers in the colon; strongly anti-inflammatory Moderate in ADHD reviews; the same depletion recurs across psychiatric diagnoses[12][13]
Blautia Elevated Carbohydrate-fermenting Firmicutes genus with mixed metabolic effects Moderate — significant in pooled analysis with no heterogeneity[2][3]
Lachnospiraceae (family) Elevated Large, functionally diverse family; includes both butyrate producers and non-producers Preliminary — single case-control cohort[3]
Akkermansia muciniphila Reduced Mucin degrader that helps maintain the protective mucus layer Preliminary; also flagged as potentially protective in infant cohort data[3][14]
Coprococcus Reduced Butyrate producer; depleted across multiple psychiatric conditions Preliminary but replicated across disorders[13][14]
Cyclohexadienyl-dehydratase carriers Elevated Bacteria carrying an enzyme in phenylalanine synthesis, upstream of dopamine Single cohort, mechanistically interesting[9]

Meta-analytic detail worth knowing: Blautia was significantly elevated in a pooled analysis of eight studies comparing 316 people with ADHD to 359 controls, with no measurable heterogeneity between studies.[2] A separate pooled analysis found significantly reduced Lactobacillus and Bifidobacterium alongside higher Firmicutes and Proteobacteria.[1] And a 59-study analysis spanning psychiatric diagnoses found depleted Faecalibacterium and Coprococcus with enriched Eggerthella consistently shared across major depressive disorder, bipolar disorder, psychosis and schizophrenia, and anxiety — evidence that this butyrate-depletion signature is transdiagnostic rather than a candidate ADHD marker. ADHD contributed few studies to that analysis, so the pattern has not been established in ADHD specifically.[13]

The Short-Chain Fatty Acid Deficit

The most consistent functional finding is not a bacterium but a metabolite class. In a case-control study of 42 children and adolescents with ADHD versus 31 healthy controls (ages 6-18), the ADHD group showed significantly reduced alpha diversity across three indices, elevated Blautia and Lachnospiraceae, reduced Akkermansia and Ruminococcaceae, and significantly lower fecal acetic, propionic, isobutyric, isovaleric and valeric acids. Butyric acid alone did not differ significantly.[3]

This matters because SCFAs are the main currency through which fiber intake reaches the brain. In the synbiotic trial literature, plasma SCFA concentrations correlated negatively with inflammatory markers, and supplementation raised propionic acid in medicated children.[11]

Where the Data Disagree

Microbial diversity findings genuinely conflict. One study reported reduced alpha diversity in young patients with ADHD independent of medication status[15], and the 2024 case-control study above found the same.[3] Yet a pooled analysis of eight studies reported a higher Shannon diversity index in ADHD — though that significance did not survive sensitivity analysis, because heterogeneity between the studies was very high.[2] Diversity is probably the wrong metric here; which organisms are present and what they produce appears more informative than how many species there are.

Digestive Problems in ADHD: Constipation, IBS, and Abdominal Pain

This is the part of the ADHD-gut relationship with the firmest numbers, and it is the part most often ignored.

GI outcome Finding in ADHD Source
Irritable bowel syndrome OR 1.63 (95% CI 1.45-1.83) — significant 11 studies, 3,851,163 individuals[4]
All intestinal disorders pooled OR 1.25 (95% CI 0.75-2.07) — not significant Same meta-analysis[4]
Constipation and flatulence Reported significantly more often than by healthy controls; pooled constipation odds did not reach significance Same meta-analysis[4]
Abdominal pain on methylphenidate (cross-over trials) RR 1.61 (95% CI 1.27-2.04) 33 trials, 1,837 participants[5]
Abdominal pain on methylphenidate (parallel trials) RR 1.30 (95% CI 1.00-1.69) — borderline 13 trials[5]
Decreased appetite on methylphenidate (parallel trials) RR 3.66 (95% CI 2.56-5.23) 16 trials, 2,962 participants[5]

Read that table carefully, because the honest reading is more interesting than the headline. The association with IBS is specific and reasonably strong. The association with intestinal disease in general is not — when all bowel disorders were pooled, the effect disappeared. So ADHD does not come with a blanket increase in gut disease; it comes with a specific overlap with functional gut disorders, the same category in which gut-brain signaling is most implicated.[4]

For families, the practical implication is that recurring stomach aches in a child with ADHD have at least three plausible and non-exclusive explanations: functional gut-brain overlap, medication side effects, and behavioral factors such as selective eating, low fiber intake and delayed toileting that are themselves common in ADHD. Constipation responds to ordinary constipation management regardless of which explanation dominates, and it is worth treating on its own merits — untreated constipation degrades sleep, appetite and concentration in anyone.

Persistent or severe gastrointestinal symptoms should be assessed by a clinician rather than attributed to ADHD. Weight loss, blood in stool, night-time pain or growth faltering are not features of ADHD and warrant investigation.

ADHD Medication and Gut Health

Anyone searching for whether their stimulant is affecting their gut deserves a straight answer, so here is what is and is not known.

What is well established: methylphenidate causes gastrointestinal adverse events at meaningfully higher rates than placebo. Pooled across randomized trials, decreased appetite was roughly 3.7 times more likely in parallel-group designs, and abdominal pain roughly 1.6 times more likely in cross-over designs.[5] These are common, usually manageable, and generally not a reason to stop treatment — but they are real and should be reported to the prescriber rather than endured.

What is preliminary: stimulants appear to be associated with microbiome differences. In a study of 63 children with ADHD (33 medicated versus 30 unmedicated), psychostimulant use was associated with detectable differences in bacterial gut microbiome composition.[16] A separate small case-control study comparing ten unmedicated ADHD children, ten psychostimulant-medicated ADHD children and ten controls found that the medicated group had the lowest microbial evenness and diversity and the most pronounced reductions in acetic, propionic and butyric acids.[17] With ten children per group, that finding is hypothesis-generating, not conclusive.

What is essentially unstudied: amphetamine-class stimulants. Almost all of the gut-related trial data concerns methylphenidate. Claims specifically about amphetamine salts and the microbiome are not currently supported by published human evidence.

What this does not mean: it does not mean medication is damaging the gut in a way that should prompt stopping it. Appetite suppression reduces food and fiber intake, which alone would be expected to shift microbial composition and lower SCFA output — so diet may be mediating much of what looks like a direct drug effect. Never adjust or discontinue prescribed ADHD medication based on microbiome research. Discuss GI side effects with the prescribing clinician, who can adjust timing, formulation or dose.

A practical point that follows directly from the appetite data: if a stimulant is suppressing appetite, fiber is usually the first thing to disappear from the diet. Protecting fiber intake at the meals that are still eaten — typically breakfast and evening meal — is a reasonable, low-risk response.

Diet, the Microbiome, and ADHD Symptoms

Diet is the intervention with the longest track record in ADHD and the clearest microbial plausibility.

The INCA randomized trial found that a restricted elimination diet significantly improved ADHD behaviors in a substantial proportion of children, with symptoms returning on food reintroduction.[18] One hypothesis is that specific foods influence symptoms partly through effects on gut microbial composition and metabolite output. Research examining dietary patterns in children with ADHD has found associations between specific bacterial taxa and dietary habits, consistent with that idea.[19]

Practically, three dietary levers have both microbial and behavioral rationale:

  • Fiber diversity. Butyrate producers are the taxa most consistently depleted in ADHD cohorts, and they depend on fermentable fiber. A range of plant fibers supports them better than a single supplement; our guide to prebiotic foods covers the practical sources.
  • Omega-3 intake. Children with ADHD show lower blood EPA and DHA than controls, and supplementation trials show benefit in meta-analysis when treatment runs four months or longer.
  • Reducing ultra-processed foods and additives. These are associated with both microbial dysbiosis and, in some children, worsened attention and behavior. Replacing them with whole foods addresses both at once.[18]

Elimination diets are restrictive, carry nutritional risk in growing children, and should only be attempted under clinical supervision. They are a diagnostic tool for identifying triggers, not a long-term eating pattern.

Probiotics for ADHD: What the Trials Show

Three strains have human data specific to ADHD, and all were tested as adjuncts to medication rather than alternatives to it.

  • Lactobacillus acidophilus LB added to atomoxetine in 80 children and adolescents over 12 weeks improved parent-rated symptom scores (Conners and CBCL total T scores) compared with atomoxetine alone. Within-group error rates on the Wisconsin Card Sorting Test also fell, but that improvement was not significant against the control group.[20]
  • Bifidobacterium bifidum at 5 billion CFU/day alongside methylphenidate in 102 children over 12 weeks improved continuous performance test measures versus placebo plus methylphenidate.[21]
  • Lactobacillus rhamnosus GG has preventive rather than treatment evidence: in a randomized trial with 13-year follow-up, ADHD or Asperger syndrome was diagnosed in 6 of 35 placebo children and 0 of 40 probiotic-supplemented children.[22] This is a single trial and requires replication.
  • A synbiotic (multi-strain plus fiber) trial in 182 children and adults was negative on its main question: synbiotic and placebo improved ADHD symptoms equally, and neither affected daily functioning. Secondary and subgroup analyses found reduced restricted and repetitive behaviors in children and improved emotion regulation in adults, with the clearest effects in participants who had elevated inflammatory markers at baseline.[23]

These are small trials with short durations, and none supports using probiotics instead of established treatment. Dosing ranges, strain selection and trial design are covered in detail in our ADHD gut-brain axis protocol, which also exists as a downloadable 16-page PDF protocol with full citations. For general strain selection principles, see the probiotic strain comparison.

ADHD and Gut Health in Children vs Adults

Most of the ADHD microbiome literature studies children, which limits what can be said about adults.

In children, the signal is strongest and best characterized: reduced butyrate producers, elevated Blautia, lower fecal SCFAs, and higher rates of constipation and abdominal pain.[3][4] The developmental angle is also unique to childhood. A Swedish birth cohort following 16,440 children for over 20 years, of whom 1,197 received a neurodevelopmental diagnosis including ADHD, found that infant gut microbes and metabolites differed between children who later received a diagnosis and those who did not — with absence of Coprococcus and presence of Citrobacter among the associated features, alongside non-microbial factors such as early-life infection, antibiotic exposure and parental smoking.[14] Associations of this kind identify risk markers; they do not identify causes, and nothing in that data supports altering an infant's care on the basis of a stool test.

In adults, the data are thinner. Adults with ADHD show gut microbiome differences from controls[16], and adult participants in the synbiotic trial showed elevated circulating adhesion molecules and lower SCFAs than controls; that trial showed no benefit over placebo on ADHD symptoms overall, with improved emotion regulation confined to a subgroup analysis.[23][11] Adult ADHD also carries a longer history of medication exposure, dietary pattern, alcohol use and comorbidity, all of which shape the microbiome independently — which makes adult cohorts harder to interpret, not easier.

Overlap with other conditions is substantial in both age groups. The butyrate-depletion signature reported in ADHD cohorts is not unique to ADHD: the same depletion is consistently found in depression, bipolar disorder, schizophrenia and anxiety, and gut symptoms cluster with sleep disorders and autism spectrum conditions too.[13]

Microbiome-Based Management Strategies

Microbiome-targeted strategies for ADHD remain largely investigational, and established treatments should not be discontinued in favor of unproven approaches. Several measures may nonetheless be worth discussing with a healthcare provider as complements.

Addressing GI Comorbidities

Gastrointestinal complaints are more common in ADHD, and the IBS association is now quantified.[4] Treating constipation, reflux or other GI symptoms improves comfort and may reduce the functional burden of those comorbidities. Clinicians should be alert to GI symptoms in ADHD patients, as they may be underreported — particularly in children with communication difficulties.[8]

  • Evidence Level: Clinical practice recommendation

Dietary Fiber and Whole-Food Patterns

Diverse plant fibers feed the butyrate producers depleted in ADHD cohorts, while reducing ultra-processed food lowers exposure to additives independently associated with behavioral change in some children. Research has found associations between dietary patterns and both gut microbiome composition and ADHD symptom severity.[19][18]

  • Evidence Level: Moderate (dietary effects on ADHD symptoms); Preliminary (microbiome-mediated mechanisms)

Omega-3 Fatty Acid Supplementation

Not strictly a microbiome intervention, but omega-3 fatty acids may support both brain function and gut microbial health. Some evidence suggests omega-3 supplementation increases beneficial bacteria including Bifidobacterium and Lactobacillus while modulating neuroinflammatory pathways relevant to ADHD.[7]

  • Evidence Level: Moderate (omega-3 and ADHD symptoms); Preliminary (omega-3-microbiome interactions)

What the Research Still Doesn't Know

Honest limits matter more than optimistic extrapolation on a question like this one.

Causal direction is unresolved. Every human study cited here is observational or a short intervention trial. Mouse transfer experiments show an ADHD-associated microbiome can alter brain biology[6], but that is not the same as showing it does so in people, or that correcting the microbiome would change symptoms.

Medication confounds nearly everything. Stimulants suppress appetite, alter what is eaten, and change gut transit. Distinguishing a drug effect from a diet effect from an ADHD effect requires treatment-naive cohorts, and few studies have them.[17]

No microbial signature is ADHD-specific. The clearest findings — depleted butyrate producers, enriched Eggerthella — recur across psychiatric diagnoses rather than distinguishing ADHD from depression or anxiety.[13] There is no validated stool test for ADHD, and any product claiming otherwise is ahead of the evidence.

Subtype differences are unexplored. ADHD presentations differ (predominantly inattentive, predominantly hyperactive-impulsive, combined), and whether they carry different microbial profiles is largely unstudied.

Probiotic trials are small and short. The two ADHD-specific probiotic RCTs ran 12 weeks with roughly 80 and 100 participants respectively.[20][21] Effects on cognitive test measures do not automatically translate to real-world functioning.

The most defensible position today is that gut health is a genuine and under-treated dimension of living with ADHD — particularly the GI comorbidity — rather than a hidden cause of it.


This page is a research summary and does not constitute medical advice. ADHD is a clinical diagnosis requiring professional assessment, and prescribed medication should never be changed or discontinued without consulting the prescribing clinician. Discuss any dietary change, elimination diet or supplement with a qualified healthcare provider, particularly for children.

Common Symptoms

Inattention
Hyperactivity
Impulsivity
Difficulty with organization
Emotional dysregulation
Constipation
Abdominal pain

Microbiome Imbalances

Research has identified the following microbiome patterns commonly associated with this condition:

  • Altered Bifidobacterium species abundance
  • Reduced Faecalibacterium prausnitzii and other butyrate producers
  • Elevated Blautia
  • Lower fecal short-chain fatty acid concentrations
  • Differences in dopamine-metabolizing bacterial pathways

Research Summary

Research consistently reports that people with ADHD carry a different gut microbial profile from neurotypical peers, including reduced butyrate-producing bacteria such as Faecalibacterium prausnitzii, elevated Blautia, altered Bifidobacterium abundance, and lower fecal short-chain fatty acid concentrations. Gastrointestinal comorbidity is measurable: a 2025 meta-analysis of 3.85 million people found 1.63-fold higher odds of irritable bowel syndrome in ADHD, and stimulant medication independently raises the risk of abdominal pain and appetite loss. Causality has not been established in humans, and microbiome-directed measures are best understood as complements to established ADHD treatment.

Beneficial Microbes for This Condition

Research has identified these microorganisms as potentially beneficial for managing this condition. Click through to learn about specific strains and the clinical evidence behind them.

Frequently Asked Questions

Does gut health affect ADHD?

Gut health is associated with ADHD, but the evidence does not yet show that it causes ADHD. Studies consistently report that people with ADHD carry a different mix of gut bacteria and produce fewer short-chain fatty acids than people without ADHD, and animal work has shown that transferring ADHD-associated microbiota into mice changes brain gene expression and connectivity. What is missing is direct proof of causal direction in humans. Gut-directed measures such as fiber, diet quality and treating constipation are best viewed as complements to established ADHD treatment, not replacements for it.

Do people with ADHD have a different gut microbiome?

Yes, in aggregate. Multiple independent meta-analyses report a recurring pattern in ADHD: lower Bifidobacterium and Lactobacillus, reduced Faecalibacterium prausnitzii and other butyrate producers, and elevated Blautia. Findings for individual taxa are not consistent across every study, and measures of overall microbial diversity conflict, with some cohorts showing reduced diversity and others showing higher diversity. The differences are real at the group level but are not specific enough to diagnose ADHD from a stool sample.

Can gut problems cause ADHD symptoms?

There is no evidence that gut problems cause ADHD. There is reasonable evidence that they can worsen day-to-day function. Pain, constipation, poor sleep and appetite disturbance all degrade attention and emotional regulation in anyone, and these problems are more common in ADHD. Treating a genuine gastrointestinal problem is worthwhile on its own terms, and may reduce some of the load on attention, but it should not be expected to resolve ADHD.

Why do kids with ADHD have stomach aches and constipation?

Several factors overlap. A pooled analysis of 11 studies covering more than 3.8 million people found significantly higher odds of irritable bowel syndrome in ADHD, and patients with ADHD report constipation and flatulence more often than controls. Stimulant medication contributes independently: in meta-analyzed cross-over trials, methylphenidate raised the risk of abdominal pain roughly 1.6-fold versus placebo. Selective eating, low fiber intake, delayed toileting and disrupted routine are also common in ADHD and all promote constipation. Persistent symptoms should be assessed by a clinician rather than assumed to be part of ADHD.

Does Adderall or Ritalin affect gut health?

Stimulants clearly affect the gut, though most of the published data concern methylphenidate rather than amphetamines. A meta-analysis of randomized trials found methylphenidate raised the risk of decreased appetite roughly 3.7-fold in parallel-group trials, and of abdominal pain roughly 1.6-fold in cross-over trials, compared with placebo. Small case-control studies have also reported lower microbial diversity and lower fecal short-chain fatty acids in medicated children with ADHD compared with unmedicated children, but the samples are small and the direction of effect is not established. Amphetamine-specific microbiome data are essentially absent. Medication should never be stopped or adjusted on the basis of this research without consulting the prescribing clinician.

Are ADHD and IBS related?

They co-occur more often than chance. A 2025 systematic review and meta-analysis of 11 studies covering 3,851,163 individuals found a pooled odds ratio of 1.63 (95% CI 1.45-1.83) for irritable bowel syndrome in people with ADHD. Notably, when all intestinal disorders were pooled together the association was not statistically significant (OR 1.25, 95% CI 0.75-2.07), so the signal is specific to IBS rather than a blanket increase in bowel disease. Shared mechanisms may include gut-brain axis signaling, altered visceral sensitivity, and stress reactivity.

Do probiotics help ADHD?

Small randomized trials suggest possible benefit as an add-on to medication, not as a substitute. Lactobacillus acidophilus LB added to atomoxetine improved parent-rated symptom scores over 12 weeks, and Bifidobacterium bifidum added to methylphenidate improved continuous performance test measures over the same period. Both trials were modest in size and neither tested probiotics alone. Our full review of doses, strains and trial designs is in the ADHD gut-brain axis protocol.

Which probiotic strains have ADHD evidence?

Three have published human data specific to ADHD. Lactobacillus acidophilus LB was tested as an adjunct to atomoxetine in 80 children and adolescents. Bifidobacterium bifidum at 5 billion CFU per day was tested alongside methylphenidate in 102 children. Lactobacillus rhamnosus GG has preventive rather than treatment evidence, from a randomized trial in which no probiotic-treated infant had received an ADHD or Asperger diagnosis by age 13 compared with 6 of 35 placebo infants. All three findings need replication in larger trials.

Is leaky gut linked to ADHD?

The link is plausible but unproven in humans. The logic runs through Faecalibacterium prausnitzii and other butyrate producers, which are reduced in ADHD cohorts; butyrate is a major fuel for colon cells and supports tight-junction integrity, so depletion could in principle increase intestinal permeability and allow bacterial endotoxin into circulation. Elevated circulating adhesion molecules have been reported in adults with ADHD, which is consistent with low-grade immune activation. Direct measurement of intestinal permeability in ADHD populations remains limited, so this should be treated as a hypothesis rather than an established mechanism.

Can changing your diet improve ADHD symptoms?

For some individuals, yes, though the effect size varies widely and the mechanism is not settled. The INCA randomized trial found that a restricted elimination diet significantly improved behavior in a substantial proportion of children, with symptoms returning on food reintroduction. Separately, omega-3 supplementation shows benefit in meta-analysis when trials run four months or longer. Increasing dietary fiber supports the butyrate-producing bacteria that are depleted in ADHD cohorts. Elimination diets are restrictive and carry nutritional risk in children, so they should only be run under clinical supervision.

References

  1. Ghosh S, Singh S.. Microbiome dynamics in attention-deficit hyperactivity disorder: a systematic review and meta-analysis decoding the role of gut dysbiosis and potential dietary interventions. European Child & Adolescent Psychiatry. 2026;35(1):31-46. doi:10.1007/s00787-025-02822-6 ↩
  2. Wang N, Gao X, Zhang Z, Yang L.. Composition of the gut microbiota in attention deficit hyperactivity disorder: a systematic review and meta-analysis. Frontiers in Endocrinology. 2022;13:838941. doi:10.3389/fendo.2022.838941 ↩
  3. Steckler R, Magzal F, Kokot M, Walkowiak J, Tamir S.. Disrupted gut harmony in attention-deficit/hyperactivity disorder: dysbiosis and decreased short-chain fatty acids. Brain, Behavior, & Immunity - Health. 2024;40:100829. doi:10.1016/j.bbih.2024.100829 ↩
  4. Ng RWY, Chen Z, Yang L, et al.. Association between attention-deficit/hyperactivity disorders and intestinal disorders: a systematic review and meta-analysis. Scientific Reports. 2025;15:19278. doi:10.1038/s41598-025-04303-x ↩
  5. Holmskov M, Storebo OJ, Moreira-Maia CR, et al.. Gastrointestinal adverse events during methylphenidate treatment of children and adolescents with attention deficit hyperactivity disorder: a systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials. PLoS ONE. 2017;12(6):e0178187. doi:10.1371/journal.pone.0178187 ↩
  6. Tengeler AC, Dam SA, Bastiaanssen TFS, et al.. Gut microbiota from persons with attention-deficit/hyperactivity disorder affects the brain in mice. Microbiome. 2020;8(1):44. doi:10.1186/s40168-020-00816-x ↩
  7. Bull-Larsen S, Mohajeri MH.. The potential influence of the bacterial microbiome on the development and progression of ADHD. Nutrients. 2019;11(11):2805. doi:10.3390/nu11112805 ↩
  8. Sukmajaya AC, Lusida MI, Soetjipto, Setiawati Y.. Systematic review of gut microbiota and attention-deficit/hyperactivity disorder (ADHD). Annals of General Psychiatry. 2021;20(1):12. doi:10.1186/s12991-021-00330-w ↩
  9. Aarts E, Ederveen THA, Naaijen J, et al.. Gut microbiome in ADHD and its relation to neural reward anticipation. PLoS ONE. 2017;12(9):e0183509. doi:10.1371/journal.pone.0183509 ↩
  10. Wan L, Ge WR, Zhang S, et al.. Case-control study of the effects of gut microbiota composition on neurotransmitter metabolic pathways in children with attention deficit hyperactivity disorder. Frontiers in Neuroscience. 2020;14:127. doi:10.3389/fnins.2020.00127 ↩
  11. Yang LL, Stiernborg M, Skott E, et al.. Effects of a synbiotic on plasma immune activity markers and short-chain fatty acids in children and adults with ADHD: a randomized controlled trial. Nutrients. 2023;15(5):1293. doi:10.3390/nu15051293 ↩
  12. Shirvani-Rad S, Ejtahed HS, Ettehad Marvasti F, et al.. The role of gut microbiota-brain axis in pathophysiology of ADHD: a systematic review. Journal of Attention Disorders. 2022;26(13):1698-1710. doi:10.1177/10870547211073474 ↩
  13. Nikolova VL, Smith MRB, Hall LJ, et al.. Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis. JAMA Psychiatry. 2021;78(12):1343-1354. doi:10.1001/jamapsychiatry.2021.2573 ↩
  14. Ahrens AP, Hyotylainen T, Petrone JR, et al.. Infant microbes and metabolites point to childhood neurodevelopmental disorders. Cell. 2024;187(8):1853-1873.e15. doi:10.1016/j.cell.2024.02.035 ↩
  15. Prehn-Kristensen A, Zimmermann A, Tiltmann L, et al.. Reduced microbiome alpha diversity in young patients with ADHD. PLoS ONE. 2018;13(7):e0200728. doi:10.1371/journal.pone.0200728 ↩
  16. Stiernborg M, Debelius JW, Yang LL, et al.. Bacterial gut microbiome differences in adults with ADHD and in children with ADHD on psychostimulant medication. Brain, Behavior, and Immunity. 2023;110:310-321. doi:10.1016/j.bbi.2023.03.012 ↩
  17. Boonchooduang N, Louthrenoo O, Likhitweerawong N, et al.. Impact of psychostimulants on microbiota and short-chain fatty acids alterations in children with attention-deficit/hyperactivity disorder. Scientific Reports. 2025;15:3034. doi:10.1038/s41598-025-87546-y ↩
  18. Pelsser LM, Frankena K, Toorman J, et al.. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial. Lancet. 2011;377(9764):494-503. doi:10.1016/S0140-6736(10)62227-1 ↩
  19. Wang LJ, Yang CY, Chou WJ, et al.. Gut microbiota and dietary patterns in children with attention-deficit/hyperactivity disorder. European Child & Adolescent Psychiatry. 2020;29(3):287-297. doi:10.1007/s00787-019-01352-2 ↩
  20. Elhossiny RM, Elshahawy HH, Mohamed HM, Abdelmageed RI.. Assessment of probiotic strain Lactobacillus acidophilus LB supplementation as adjunctive management of attention-deficit hyperactivity disorder in children and adolescents: a randomized controlled clinical trial. BMC Psychiatry. 2023;23(1):823. doi:10.1186/s12888-023-05324-4 ↩
  21. Wang LJ, Tsai CS, Chou WJ, et al.. Add-on Bifidobacterium bifidum supplement in children with attention-deficit/hyperactivity disorder: a 12-week randomized double-blind placebo-controlled clinical trial. Nutrients. 2024;16(14):2260. doi:10.3390/nu16142260 ↩
  22. Partty A, Kalliomaki M, Wacklin P, et al.. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatric Research. 2015;77(6):823-828. doi:10.1038/pr.2015.51 ↩
  23. Skott E, Yang LL, Stiernborg M, et al.. Effects of a synbiotic on symptoms, and daily functioning in attention deficit hyperactivity disorder: a double-blind randomized controlled trial. Brain, Behavior, and Immunity. 2020;89:9-19. doi:10.1016/j.bbi.2020.05.056 ↩

Related Conditions

Neurological

Autism Spectrum Disorders & Gut Health: Microbiome Research

Research explores the gut-brain connection in autism, including GI comorbidity, Clostridium overgrowth, reduced diversity, and metabolites like 4EPS.

Mental Health

Anxiety Disorders & Gut Health: The Microbiome Connection

Research links anxiety disorders to gut microbiome changes via the gut-brain axis. Explore how bacteria influence GAD, social anxiety, and panic disorder.

Digestive Health

Food Sensitivities and the Gut Microbiome

Learn how gut microbiome imbalances, intestinal permeability, and immune tolerance breakdown may contribute to food sensitivities. Evidence-based insights.

Skin Health

Gut Microbiome and Psoriasis

The gut microbiome and psoriasis are connected through systemic inflammation and immune signaling. Learn how gut health strategies may reduce symptoms.

Cardiovascular Health

Hypertension and the Gut Microbiome

Research links gut microbiome imbalances to high blood pressure. Learn how SCFAs, TMAO, and salt-sensitive bacteria may influence hypertension risk.

Cardiovascular Health

Cardiovascular Disease & Gut Health

Gut bacteria produce TMAO and other metabolites that drive cardiovascular disease risk. Learn how restoring microbiome balance may reduce heart disease.

Immune System

Frequent Infections & the Immune Microbiome

Frequent infections may be linked to gut microbiome imbalances. Explore how colonization resistance and immune training shape infection susceptibility.

Cardiovascular Health

Atherosclerosis and the Gut Microbiome

Discover how gut bacteria influence atherosclerosis through the TMAO pathway and inflammation. Learn about microbiome research on arterial plaque formation.